Singapore: EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has re...
Singapore: China Nepstar Chain Drugstore has completed the sales of its 40 percent equity ownership in Yunnan Jianzhijia...
Singapore: A team of China's National Health and Family Planning Commission (NHFPC) led by Mr Li Xi, head, Permanent Dis...
Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client deman...
Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, cel...
Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Minis...
Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It te...
Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate contro...
Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...
Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around ...
Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its...
Singapore: China Botanic Pharmaceutical (formerly Renhuang Pharmaceuticals) received a warning letter from the NYSE MKT...
Yunnan Baiyao made new strategies for 2011 and the year recorded relocation, expansion of the company's business develop...
Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to man...
Singapore: The not-for-profit organization, International Medica Foundation, that works towards the development of a saf...
Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...
China's role in the global drug industry will fundamentally change; most companies will fail to capitalize on this oppor...
